343 related articles for article (PubMed ID: 25962896)
21. Active older dancers have lower C-terminal Agrin fragment concentration, better balance and gait performance than sedentary peers.
Marcolin G; Franchi MV; Monti E; Pizzichemi M; Sarto F; Sirago G; Paoli A; Maggio M; Zampieri S; Narici M
Exp Gerontol; 2021 Oct; 153():111469. PubMed ID: 34246731
[TBL] [Abstract][Full Text] [Related]
22. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases.
Cardoso AL; Fernandes A; Aguilar-Pimentel JA; de Angelis MH; Guedes JR; Brito MA; Ortolano S; Pani G; Athanasopoulou S; Gonos ES; Schosserer M; Grillari J; Peterson P; Tuna BG; Dogan S; Meyer A; van Os R; Trendelenburg AU
Ageing Res Rev; 2018 Nov; 47():214-277. PubMed ID: 30071357
[TBL] [Abstract][Full Text] [Related]
23. Skeletal muscle is an endocrine organ.
Iizuka K; Machida T; Hirafuji M
J Pharmacol Sci; 2014; 125(2):125-31. PubMed ID: 24859778
[TBL] [Abstract][Full Text] [Related]
24. Growth differentiation factor-15 as a biomarker for sarcopenia in aging humans and mice.
Kim H; Kim KM; Kang MJ; Lim S
Exp Gerontol; 2020 Dec; 142():111115. PubMed ID: 33069782
[TBL] [Abstract][Full Text] [Related]
25. Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers.
Rentflejsz J; Wojszel ZB
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398421
[TBL] [Abstract][Full Text] [Related]
26. Loss of muscle mass: Current developments in cachexia and sarcopenia focused on biomarkers and treatment.
Drescher C; Konishi M; Ebner N; Springer J
Int J Cardiol; 2016 Jan; 202():766-72. PubMed ID: 26474466
[TBL] [Abstract][Full Text] [Related]
27. Prolonged absence of myostatin reduces sarcopenia.
Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
[TBL] [Abstract][Full Text] [Related]
28. Interactions between muscle tissues and bone metabolism.
Kawao N; Kaji H
J Cell Biochem; 2015 May; 116(5):687-95. PubMed ID: 25521430
[TBL] [Abstract][Full Text] [Related]
29. Neuromuscular Junction Aging: A Role for Biomarkers and Exercise.
Pratt J; De Vito G; Narici M; Boreham C
J Gerontol A Biol Sci Med Sci; 2021 Mar; 76(4):576-585. PubMed ID: 32832976
[TBL] [Abstract][Full Text] [Related]
30. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
31. Alpine Skiing With total knee ArthroPlasty (ASWAP): impact on molecular and architectural features of musculo-skeletal ageing.
Narici M; Conte M; Salvioli S; Franceschi C; Selby A; Dela F; Rieder F; Kösters A; Müller E
Scand J Med Sci Sports; 2015 Aug; 25 Suppl 2():33-9. PubMed ID: 26083700
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease.
Karim A; Muhammad T; Qaisar R
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575696
[TBL] [Abstract][Full Text] [Related]
33. Propeptide-mediated inhibition of myostatin increases muscle mass through inhibiting proteolytic pathways in aged mice.
Collins-Hooper H; Sartori R; Macharia R; Visanuvimol K; Foster K; Matsakas A; Flasskamp H; Ray S; Dash PR; Sandri M; Patel K
J Gerontol A Biol Sci Med Sci; 2014 Sep; 69(9):1049-59. PubMed ID: 24414825
[TBL] [Abstract][Full Text] [Related]
34. Muscle weakness and neuromuscular junctions in aging and disease.
Shigemoto K; Kubo S; Mori S; Yamada S; Akiyoshi T; Miyazaki T
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S137-47. PubMed ID: 20590829
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of sarcopenia in liver cirrhosis and the role of myokines.
Geladari E; Alexopoulos T; Kontogianni MD; Vasilieva L; Mani I; Alexopoulou A
Ann Gastroenterol; 2023; 36(4):392-404. PubMed ID: 37396001
[TBL] [Abstract][Full Text] [Related]
36. Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown.
Rom O; Kaisari S; Aizenbud D; Reznick AZ
Ann N Y Acad Sci; 2012 Jul; 1259():47-53. PubMed ID: 22758636
[TBL] [Abstract][Full Text] [Related]
37. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.
Perrini S; Laviola L; Carreira MC; Cignarelli A; Natalicchio A; Giorgino F
J Endocrinol; 2010 Jun; 205(3):201-10. PubMed ID: 20197302
[TBL] [Abstract][Full Text] [Related]
38. Serum Brain-Derived Neurotrophic Factor and Myostatin Levels Are Associated With Skeletal Muscle Mass in Kidney Transplant Recipients.
Koito Y; Yanishi M; Kimura Y; Tsukaguchi H; Kinoshita H; Matsuda T
Transplant Proc; 2021; 53(6):1939-1944. PubMed ID: 34253381
[TBL] [Abstract][Full Text] [Related]
39. Drastic increase of myosin light chain MLC-2 in senescent skeletal muscle indicates fast-to-slow fibre transition in sarcopenia of old age.
Gannon J; Doran P; Kirwan A; Ohlendieck K
Eur J Cell Biol; 2009 Nov; 88(11):685-700. PubMed ID: 19616867
[TBL] [Abstract][Full Text] [Related]
40. Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseases.
Punga AR; Ruegg MA
Curr Opin Pharmacol; 2012 Jun; 12(3):340-6. PubMed ID: 22365504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
